160 related articles for article (PubMed ID: 24472388)
1. Bovine lactoferrin ingestion protects against inflammation via IL-11 induction in the small intestine of mice with hepatitis.
Kuhara T; Tanaka A; Yamauchi K; Iwatsuki K
Br J Nutr; 2014 May; 111(10):1801-10. PubMed ID: 24472388
[TBL] [Abstract][Full Text] [Related]
2. Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine.
Iigo M; Alexander DB; Long N; Xu J; Fukamachi K; Futakuchi M; Takase M; Tsuda H
Biochimie; 2009 Jan; 91(1):86-101. PubMed ID: 18634843
[TBL] [Abstract][Full Text] [Related]
3. Bovine lactoferrin induces interleukin-11 production in a hepatitis mouse model and human intestinal myofibroblasts.
Kuhara T; Yamauchi K; Iwatsuki K
Eur J Nutr; 2012 Apr; 51(3):343-51. PubMed ID: 21688123
[TBL] [Abstract][Full Text] [Related]
4. Effect of Bovine Lactoferrin Treatment Followed by Acute Stress on the IgA-Response in Small Intestine of BALB/c Mice.
Peña-Juárez MC; Campos-Rodríguez R; Godínez-Victoria M; Cruz-Hernández TR; Reyna-Garfias H; Barbosa-Cabrera RE; Drago-Serrano ME
Immunol Invest; 2016 Oct; 45(7):652-67. PubMed ID: 27611298
[TBL] [Abstract][Full Text] [Related]
5. Bovine lactoferrin: benefits and mechanism of action against infections.
Yamauchi K; Wakabayashi H; Shin K; Takase M
Biochem Cell Biol; 2006 Jun; 84(3):291-6. PubMed ID: 16936799
[TBL] [Abstract][Full Text] [Related]
6. Modulatory Effects of Oral Bovine Lactoferrin on the IgA Response at Inductor and Effector Sites of Distal Small Intestine from BALB/c Mice.
Arciniega-Martínez IM; Campos-Rodríguez R; Drago-Serrano ME; Sánchez-Torres LE; Cruz-Hernández TR; Reséndiz-Albor AA
Arch Immunol Ther Exp (Warsz); 2016 Feb; 64(1):57-63. PubMed ID: 26318768
[TBL] [Abstract][Full Text] [Related]
7. PEGylated lactoferrin enhances its hepatoprotective effects on acute liver injury induced by D-galactosamine and lipopolysaccharide in rats.
Sugiyama A; Sato A; Shimizu H; Ando K; Takeuchi T
J Vet Med Sci; 2010 Feb; 72(2):173-80. PubMed ID: 19942815
[TBL] [Abstract][Full Text] [Related]
8. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
[TBL] [Abstract][Full Text] [Related]
9. Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production.
Zimecki M; Miedzybrodzki R; Szymaniec S
Arch Immunol Ther Exp (Warsz); 1998; 46(6):361-5. PubMed ID: 9883315
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide.
Yamaguchi M; Matsuura M; Kobayashi K; Sasaki H; Yajima T; Kuwata T
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1234-9. PubMed ID: 11687469
[TBL] [Abstract][Full Text] [Related]
11. Bovine lactoferrin promotes corneal wound healing and suppresses IL-1 expression in alkali wounded mouse cornea.
Pattamatta U; Willcox M; Stapleton F; Garrett Q
Curr Eye Res; 2013 Nov; 38(11):1110-7. PubMed ID: 23898919
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.
Machnicki M; Zimecki M; Zagulski T
Int J Exp Pathol; 1993 Oct; 74(5):433-9. PubMed ID: 8217778
[TBL] [Abstract][Full Text] [Related]
13. Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues.
Fischer R; Debbabi H; Blais A; Dubarry M; Rautureau M; Boyaka PN; Tome D
Int Immunopharmacol; 2007 Oct; 7(10):1387-93. PubMed ID: 17673154
[TBL] [Abstract][Full Text] [Related]
14. Lactoferrin lowers serum interleukin 6 and tumor necrosis factor alpha levels in mice subjected to surgery.
Zimecki M; Właszczyk A; Zagulski T; Kübler A
Arch Immunol Ther Exp (Warsz); 1998; 46(2):97-104. PubMed ID: 9613707
[TBL] [Abstract][Full Text] [Related]
15. Development of PEGylated serum albumin with multiple reduced thiols as a long-circulating scavenger of reactive oxygen species for the treatment of fulminant hepatic failure in mice.
Katsumi H; Nishikawa M; Nishiyama K; Hirosaki R; Nagamine N; Okamoto H; Mizuguchi H; Kusamori K; Yasui H; Yamashita F; Hashida M; Sakane T; Yamamoto A
Free Radic Biol Med; 2014 Apr; 69():318-23. PubMed ID: 24509159
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of pyrrolidine dithiocarbamate on TNF-alpha-mediated liver injury in two different models of fulminant hepatitis.
Lu JW; Wang H; Yan-Li J; Zhang C; Ning H; Li XY; Zhang H; Duan ZH; Zhao L; Wei W; Xu DX
J Hepatol; 2008 Mar; 48(3):442-52. PubMed ID: 18215436
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of Acanthopanax gracilistylus-extracted Acankoreanogenin A on mice with fulminant hepatitis.
Zhang BX; Li N; Zhang ZP; Liu HB; Zhou RR; Zhong BY; Zou MX; Dai XH; Xiao MF; Liu XQ; Fan XG
Int Immunopharmacol; 2011 Aug; 11(8):1018-23. PubMed ID: 21356341
[TBL] [Abstract][Full Text] [Related]
18. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
[TBL] [Abstract][Full Text] [Related]
19. Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin.
Wakabayashi H; Takakura N; Yamauchi K; Tamura Y
Clin Vaccine Immunol; 2006 Feb; 13(2):239-45. PubMed ID: 16467332
[TBL] [Abstract][Full Text] [Related]
20. The role of histamine H1 receptor and H2 receptor in LPS-induced liver injury.
Masaki T; Chiba S; Tatsukawa H; Noguchi H; Kakuma T; Endo M; Seike M; Watanabe T; Yoshimatsu H
FASEB J; 2005 Aug; 19(10):1245-52. PubMed ID: 16051691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
